TrialJournal of pharmacokinetics and pharmacodynamics2019

Concentration-response modeling of ECG data from early-phase clinical studies to assess QT prolongation risk of contezolid (MRX-I), an oxazolidinone antibacterial agent.

Junzhen Wu et al.PubMed ↗Publisher ↗

No numbers read from the abstract.